Shanghai Pharmaceuticals’ Joint Venture with Phililab to Launch Its First Overseas R&D Center

Michael Patrini

Sidley has advised Shanghai Pharmaceuticals Holding Co. Ltd. (HKEX: 2607) (SSE: 601607) (SPH) on its joint venture with Phililab, Inc. (Phililab) through its Delaware subsidiary, SPH…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Michael Patrini

…

This content is for Standard 1 Year members only.
Login Join Now